Accounts Receivable & Other

Current Assets

UnitedHealth Group Accounts Receivable & Other decreased by 5.6% to $554.00M in Q3 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ2 2022
Last reportedQ3 2025

How to read this metric

An increase may signal growth in business volume or potential collection delays, while a decrease indicates efficient cash conversion cycles.

Detailed definition

This includes amounts owed to the firm by clients or counterparties for services rendered, trading settlements, or other...

Peer comparison

Standard line item across financial services firms, though composition varies based on business mix.

Metric ID: accounts_receivable_net_and_other

Historical Data

6 periods
 Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q3 '25
Value$585.00M$550.00M$530.00M$550.00M$587.00M$554.00M
QoQ Change-6.0%-3.6%+3.8%+6.7%-5.6%
YoY Change-6.0%+6.7%
Range$530.00M$587.00M
CAGR-4.3%
Avg YoY Growth+0.4%
Median YoY Growth+0.4%

Accounts Receivable & Other at Other Companies

Frequently Asked Questions

What is UnitedHealth Group's accounts receivable & other?
UnitedHealth Group (UNH) reported accounts receivable & other of $554.00M in Q3 2025.
What does accounts receivable & other mean?
Money owed to the company by clients and counterparties for services or transactions.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.